DSS, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DSS research report →
Price Chart
About the company
DSS, Inc. is a globally diversified enterprise with operations across numerous industries. In product packaging, the company specializes in manufacturing and distributing custom folding cartons, mailers, photo sleeves, and advanced three-dimensional direct mail products.
- CEO
- Jason T. Grady
- IPO
- 1994
- Employees
- 102
- HQ
- West Henrietta, NY, US
Get TickerSpark's AI analysis on DSS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.52M
- P/E
- -0.19
- PEG
- -0.00
- P/S
- 0.30
- P/B
- -14.72
- EV/EBITDA
- -1.62
- Div Yield
- 0.00%
- Gross Margin
- -20.80%
- Op Margin
- -89.72%
- Net Margin
- -149.84%
- ROE
- -675.92%
- ROIC
- -31.61%
Latest fiscal year · YoY change
- Revenue
- $20.76M+8.7%
- Gross Profit
- $-2,169,000+51.2%
- Op Income
- $-14,434,000
- Net Income
- $-23,929,000+49.0%
- EPS
- $-2.66+59.9%
- OCF Growth
- -0.5%
- FCF Growth
- -2.4%
- 52W High
- $1.90
- 52W Low
- $0.36
- 50D MA
- $0.57
- 200D MA
- $0.81
- Beta
- 0.98
- RSI (14)
- 53
- Avg Volume
- 1.45M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
DSS posted a softer quarter overall, but AuthentiGuard growth, Asia-Pacific expansion, and a planned non-cash debt resolution were the main positives.· May 16, 2018
- Aggregated revenues fell 8% year over year, driven by an 11% decline in Printed Products to $3.9 million.
- Technology sales were strong, with digital authentication products and services, including AuthentiGuard, up 172% to $177,000.
- Total costs and expenses fell 3% as a 99% drop in stock-based compensation was partly offset by higher professional fees and R&D.
- The company reported a net loss of $406,000 and said adjusted EBITDA was lower than last year but still positive for the eighth straight quarter.
- Management highlighted Hong Kong/Asia-Pacific expansion and said a $3.7 million debt is expected to be settled on a non-cash basis, creating an estimated $3.3 million gain on extinguishment.
For Q1 2018, aggregated revenues decreased 8% year over year. Printed Products revenue was $3.9 million, down 11%, while digital authentication products and services, including AuthentiGuard, were $177,000, up 172% year over year. Total cost and expenses decreased 3%, and the company reported a net loss of $406,000. Management said adjusted EBITDA was still positive for the eighth consecutive quarter, though lower than Q1 2017. Looking ahead, the company emphasized continued investment in Asia-Pacific and AuthentiGuard, but did not give formal next-quarter or full-year revenue/EPS guidance on the call.
CEO Jeff Ronaldi framed the quarter around two strategic priorities: accelerating AuthentiGuard and expanding into Asia-Pacific. He said Hong Kong is a key base for counterfeiting-related opportunities and described active sales calls across Hong Kong, China, Malaysia, the Philippines, India, and Australia. He was upbeat about the company’s ability to integrate into customer supply chains with minimal disruption and about the blockchain-related research project with the Hong Kong R&D Centre.
CFO Phil Jones focused on the mixed operating picture and the balance sheet. He said the revenue decline was largely due to timing after a very strong Q4 in Printed Products, while technology sales rose sharply; he also noted costs fell 3% despite higher professional fees and R&D tied to litigation, Asia hiring, and the blockchain project. On the balance sheet, he said unrestricted cash was $3.7 million and net current assets were $8.1 million as of March 31, 2018, and he described the approximately $3.7 million debt as expected to be settled through a patent transfer, with an estimated $3.3 million gain on extinguishment.
There was no substantive analyst Q&A because no questions were asked. Management did not face follow-up on the revenue decline, Asia expansion costs, or the debt settlement issue. The call ended after brief closing remarks from management and IR.
The bullish case is that AuthentiGuard is gaining traction, with 172% growth in the quarter, and management sees that product line expanding as customers roll it out globally. The company is also building an Asia-Pacific footprint through Hong Kong, sales activity in multiple countries, and a blockchain-focused research partnership that management believes can support future anti-counterfeit offerings.
The bear case is that core revenues fell 8% and Printed Products remained lumpy, with management acknowledging the quarter was softer after a big Q4. The company also faced higher professional fees and R&D, ongoing litigation-related costs, and an unresolved debt situation that, while expected to be non-cash, still required finalizing an agreement.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 27.2%
- Shares Outstanding
- 10.04M
- Float Shares
- 2.73M
of shares held by institutions
15 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 64.83K | 0 |
| Cwm, LLC | 1 | ▲ 1 |
Held by 4 ETFs
Biggest fund positions in DSS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | Chan Heng Fai Ambrose | other | 16,554,055 |
| Jun 3, 26 | Chan Heng Fai Ambrose | other | 0 |
| Aug 28, 25 | Chan Heng Fai Ambrose | sell | 130,679 |
| Aug 20, 25 | Chan Heng Fai Ambrose | other | 0 |
| Aug 20, 25 | Chan Heng Fai Ambrose | other | 581,395 |
| Feb 6, 25 | Chan Heng Fai Ambrose | other | 1,000,000 |
| Dec 10, 24 | Chan Heng Fai Ambrose | buy | 820,597 |
| Dec 10, 24 | Chan Heng Fai Ambrose | buy | 205,149 |
| Dec 29, 23 | Wu William Wai Leung | sell | 1,020 |
| Dec 28, 23 | Chan Heng Fai Ambrose | buy | 672,173 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DSS coverage
Recent articles, reports, and earnings notes.
No research on DSS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DSS report →DSS, Inc. Withdraws Registration Statement
globenewswire.com · Jun 9
ImmunityBio Announces FDA Acceptance of Supplemental BLA for ANKTIVA® Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Papillary Disease; PDUFA Date Set for January 6, 2027
gurufocus.com · May 19
DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
globenewswire.com · May 8
DSS, Inc. Letter to Shareholders
globenewswire.com · Apr 15
DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering
globenewswire.com · Feb 5
DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering
globenewswire.com · Feb 4
DSS, Inc. Announces Launch of Proposed Public Offering
globenewswire.com · Feb 3
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth
globenewswire.com · May 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.